DRKS00031596招募中不适用
Validation of novel ECG Parameters to detect Fabry disease and other cardiomyopathies - DETECT
Sana Klinikum Lichtenberg0 个研究点目标入组 600 人开始时间: 2023年5月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Existing cardiomyopathy: Fabry disease, amyloidosis, hypertrophic cardiomyopathy, aortic valve stenosis, and healthy controls with ECGs
排除标准
- •Insufficient quality of the ECGs
研究者
相似试验
尚未招募
Unknown
Development of a diagnostic method for cardiac amyloidosis by delayed contrast imaging of myocardium using CT.cardiac amyloidosisJPRN-UMIN000053389Fukushima Medical University80
已完成
不适用
Detection of Ventricular Fibrillation via the Left Ventricular Lead Implanted for Resynchronization TherapyJPRN-UMIN000008773Chiba University Graduate School of Medicine Department of Cardiovascular Science and Medicine40
尚未招募
不适用
Developing an ECG parameter for the diagnosis of CAD in Chronic Stable Angina patientsCTRI/2021/08/035729Kasturba Medical College and Hospital
已完成
不适用
Markers to Determine Arrhythmia Vulnerability in End Stage Heart Failure.reduced heart function10007521heart failurearrhythmiaNL-OMON39922Academisch Medisch Centrum20
尚未招募
不适用
VAlidation of Non-invasive fetal ECG monitor in high risk pregnancies (VANIE) - Pilot studyPregnancyHigh risk pregnancyReproductive Health and Childbirth - Antenatal careReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12620001180909niversity of Technology Sydney50